サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1526852

アップストリームバイオプロセシングの世界市場レポート 2024年

Upstream Bioprocessing Global Market Report 2024
出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
アップストリームバイオプロセシングの世界市場レポート 2024年
出版日: 2024年08月05日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

アップストリームバイオプロセシングの市場規模は、今後数年で急成長が見込まれ、2028年にはCAGR 13.3％で198億4,000万米ドルに成長する見通しです。予測期間の成長は、単回使用バイオリアクターの商業利用、バイオ医薬品製造のアウトソーシング、製薬・バイオテクノロジー産業の急成長、単回使用アップストリームバイオプロセシングの採用増加、パートナーシップ、合併、買収、コラボレーションの増加に起因しています。予測期間における主な動向としては、バイオ医薬品業界における研究開発投資の増加、技術の進歩、高度なアップストリームバイオプロセシング技術、新技術の開発、高度なろ過技術などが挙げられます。

アップストリームバイオプロセシング市場の成長は、バイオ医薬品製造のアウトソーシングによって促進されると予想されます。このアウトソーシングは、製造受託機関（CMO）や開発・製造受託機関（CDMO）といった外部の事業体に特定の製造段階を委ねることを含みます。アウトソーシングの背景には、コスト効率、コアコンピタンスへの集中、生産規模の柔軟性、専門知識へのアクセス、リスクの軽減といった要因があります。バイオ医薬品製造のアウトソーシングは、外部の専門知識を活用し、業務を合理化し、コストを削減することで、製品開発を加速させる。例えば、BDO USAの予測では、2025年までに、開発・製造受託会社とハイブリッド製造会社が、世界の哺乳類生産能力（約7500kL）の44％を支配することになります。したがって、バイオ医薬品製造のアウトソーシングは、アップストリームバイオプロセシング市場の成長の主要な促進要因となっています。

アップストリームバイオプロセシング市場の大手企業は、細胞培養プロセスに合わせた高度なバイオリアクターの開発に注力し、性能、柔軟性、拡張性を高めています。バイオリアクターはアップストリームバイオプロセシングにおいて極めて重要なツールであり、細胞培養や生体分子製造を通じて効率的かつ制御されたバイオ医薬品生産を可能にします。例えば、2023年4月、Cytiva社は、単回使用アップストリームバイオプロセシング手順を合理化するために設計されたX-platformバイオリアクターを発表しました。これらのバイオリアクターは、タンク、キャビネットアセンブリ、ヒューマンマシンインターフェース（HMI）で構成されるモジュールデザインを特徴としており、カスタムハードウェアや単回使用バッグを必要とせずに柔軟なアレンジが可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 市場促進要因・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模の実績と成長, 2018-2023
  • 市場規模の予測と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のアップストリームバイオプロセシング市場：製品タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • バイオリアクター
  • 発酵槽
  • 細胞培地
  • フィルター
  • バッグ・容器
  • 世界のアップストリームバイオプロセシング市場：ワークフロー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 培地準備
  • 細胞培養
  • 細胞分離
  • 世界のアップストリームバイオプロセシング市場：使用タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 単回使用
  • 多回使用
  • 世界のアップストリームバイオプロセシング市場：モード別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 社内
  • アウトソーシング
  • 世界のアップストリームバイオプロセシング市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • CDMOまたはCRO
  • 研究・学術機関
  • バイオ医薬品企業

第7章 地域別・国別分析

  • 世界のアップストリームバイオプロセシング市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のアップストリームバイオプロセシング市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • アップストリームバイオプロセシング市場：競合情勢
  • アップストリームバイオプロセシング市場：企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Danaher Corp
    • Merck KGaA
    • GE HealthCare Technologies
    • Parker Hannifin Corp

第31章 その他の大手企業と革新的企業

  • Corning Inc.
  • AGC Biologics
  • Avantor
  • AGC Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Sartorius AG
  • Entegris Inc.
  • Getinge AB
  • Bio-Rad Laboratories Inc.
  • Samsung Biologics Co. Ltd.
  • Eppendorf AG
  • Repligen Corporation
  • Takara Bio Inc.
  • KBI Biopharma Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18501

Upstream bioprocessing involves preparing and cultivating cells to produce biological products such as proteins and vaccines. It focuses on cell line development and cell culture to create a scalable system that maximizes yield and quality, ensuring reproducibility and efficiency for downstream purification and formulation.

The primary products of upstream bioprocessing include bioreactors, fermenters, cell culture media, filters, and bags and containers. Bioreactors are vessels or tanks where biological reactions and processes occur under controlled conditions. The workflow includes media preparation, cell culture, and cell separation, with usage options including single-use and multi-use systems. These processes can be performed in-house or outsourced by various end users such as contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), research and academic institutes, and biopharmaceutical companies.

The upstream bioprocessing market research report is one of a series of new reports from The Business Research Company that provides upstream bioprocessing market statistics, including upstream bioprocessing industry global market size, regional shares, competitors with a upstream bioprocessing market share, detailed upstream bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the upstream bioprocessing industry. This upstream bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The upstream bioprocessing market size has grown rapidly in recent years. It will grow from $10.63 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to the increased need for process optimization and contamination-free, safe, and efficient production of biomolecules, commercial success, and rising demand for biotherapeutics. Additionally, there was a rise in the implementation of process analytical technology, an increase in chronic disease prevalence, and heightened research into the production of biosimilars.

The upstream bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $19.84 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the commercial use of single-use bioreactors, the outsourcing of biopharmaceutical manufacturing, the rapid growth of the pharmaceutical and biotechnology industries, the rising adoption of single-use upstream bioprocessing, and increasing partnerships, mergers, acquisitions, and collaborations. Major trends in the forecast period include increasing investments in R&D in the biopharmaceutical industry, technological advancements, advanced upstream bioprocessing technologies, the development of new technologies, and advanced filtration technologies.

The growth of the upstream bioprocessing market is expected to be propelled by the outsourcing of biopharmaceutical manufacturing. This outsourcing involves delegating certain production stages to external entities such as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). It is driven by factors such as cost efficiency, focus on core competencies, flexibility in production scaling, access to specialized expertise, and risk mitigation. Outsourcing biopharmaceutical manufacturing accelerates product development by leveraging external expertise, streamlining operations, and reducing costs. For instance, BDO USA predicts that by 2025, contract development and manufacturing organizations along with hybrid manufacturing companies will control 44% of the global mammalian capacity of around 7,500kL. Hence, the outsourcing of biopharmaceutical manufacturing is a key driver of the upstream bioprocessing market's growth.

Leading companies in the upstream bioprocessing market are concentrating on developing advanced bioreactors tailored to cell culture processes, enhancing performance, flexibility, and scalability. Bioreactors are crucial tools in upstream bioprocessing, enabling efficient and controlled biopharmaceutical production through cell culture and biomolecule manufacturing. For example, in April 2023, Cytiva introduced X-platform bioreactors designed to streamline single-use upstream bioprocessing procedures. These bioreactors feature a modular design consisting of a tank, cabinet assembly, and human-machine interface (HMI), allowing flexible arrangements without the need for custom hardware or single-use bags. User-friendly features include an optimized vessel with a full-opening door, baffles, and improved cable management. Additionally, the online Bioreactor Scaler tool aids in determining optimal parameters for successful scale-up.

In May 2022, Lonza entered into a license agreement with Adva Biotechnology, granting Adva access to key intellectual property for the global expansion of automated bioreactors. This agreement provides Adva Biotechnology with a non-exclusive license to specific patents in Lonza's portfolio related to smart automation and bioreactor control. Adva Biotechnology, based in Israel, is focused on developing innovative technologies for upstream bioprocessing in the cell therapy industry.

Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology

North America was the largest region in the upstream bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the upstream bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The upstream bioprocessing market consists of revenues earned by entities by providing services such as cell line development, inoculum preparation, process development and optimization, scale-up production, quality control and monitoring and raw material supply and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The upstream bioprocessing market also includes sales of recombinant proteins, monoclonal antibodies, vaccines, gene therapy vectors, cell therapy products, enzymes, peptides, bio therapeutics and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Upstream Bioprocessing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on upstream bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for upstream bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The upstream bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product type: Bioreactors; Fermenters; Cell Culture Media; Filters; Bags And Containers
  • 2) By Workflow: Media Preparation; Cell Culture; Cell Separation
  • 3) By Usage type: Single-Use; Multi-Use
  • 4) By Mode: In House; Outsourced
  • 5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs); Research And Academic Institutes; Biopharmaceutical Companies
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corp; Merck KGaA; GE HealthCare Technologies; Parker Hannifin Corp
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Upstream Bioprocessing Market Characteristics

3. Upstream Bioprocessing Market Trends And Strategies

4. Upstream Bioprocessing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Upstream Bioprocessing Market Size and Growth

  • 5.1. Global Upstream Bioprocessing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Upstream Bioprocessing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Upstream Bioprocessing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Upstream Bioprocessing Market Segmentation

  • 6.1. Global Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bioreactors
  • Fermenters
  • Cell Culture Media
  • Filters
  • Bags And Containers
  • 6.2. Global Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Media Preparation
  • Cell Culture
  • Cell Separation
  • 6.3. Global Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single-Use
  • Multi-Use
  • 6.4. Global Upstream Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In House
  • Outsourced
  • 6.5. Global Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs)
  • Research And Academic Institutes
  • Biopharmaceutical Companies

7. Upstream Bioprocessing Market Regional And Country Analysis

  • 7.1. Global Upstream Bioprocessing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Upstream Bioprocessing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Upstream Bioprocessing Market

  • 8.1. Asia-Pacific Upstream Bioprocessing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Upstream Bioprocessing Market

  • 9.1. China Upstream Bioprocessing Market Overview
  • 9.2. China Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Upstream Bioprocessing Market

  • 10.1. India Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Upstream Bioprocessing Market

  • 11.1. Japan Upstream Bioprocessing Market Overview
  • 11.2. Japan Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Upstream Bioprocessing Market

  • 12.1. Australia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Upstream Bioprocessing Market

  • 13.1. Indonesia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Upstream Bioprocessing Market

  • 14.1. South Korea Upstream Bioprocessing Market Overview
  • 14.2. South Korea Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Upstream Bioprocessing Market

  • 15.1. Western Europe Upstream Bioprocessing Market Overview
  • 15.2. Western Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Upstream Bioprocessing Market

  • 16.1. UK Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Upstream Bioprocessing Market

  • 17.1. Germany Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Upstream Bioprocessing Market

  • 18.1. France Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Upstream Bioprocessing Market

  • 19.1. Italy Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Upstream Bioprocessing Market

  • 20.1. Spain Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Upstream Bioprocessing Market

  • 21.1. Eastern Europe Upstream Bioprocessing Market Overview
  • 21.2. Eastern Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Upstream Bioprocessing Market

  • 22.1. Russia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Upstream Bioprocessing Market

  • 23.1. North America Upstream Bioprocessing Market Overview
  • 23.2. North America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Upstream Bioprocessing Market

  • 24.1. USA Upstream Bioprocessing Market Overview
  • 24.2. USA Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Upstream Bioprocessing Market

  • 25.1. Canada Upstream Bioprocessing Market Overview
  • 25.2. Canada Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Upstream Bioprocessing Market

  • 26.1. South America Upstream Bioprocessing Market Overview
  • 26.2. South America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Upstream Bioprocessing Market

  • 27.1. Brazil Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Upstream Bioprocessing Market

  • 28.1. Middle East Upstream Bioprocessing Market Overview
  • 28.2. Middle East Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Upstream Bioprocessing Market

  • 29.1. Africa Upstream Bioprocessing Market Overview
  • 29.2. Africa Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Upstream Bioprocessing Market Competitive Landscape And Company Profiles

  • 30.1. Upstream Bioprocessing Market Competitive Landscape
  • 30.2. Upstream Bioprocessing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corp
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE HealthCare Technologies
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Parker Hannifin Corp
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Upstream Bioprocessing Market Other Major And Innovative Companies

  • 31.1. Corning Inc.
  • 31.2. AGC Biologics
  • 31.3. Avantor
  • 31.4. AGC Inc.
  • 31.5. Boehringer Ingelheim International GmbH
  • 31.6. Catalent Inc.
  • 31.7. Sartorius AG
  • 31.8. Entegris Inc.
  • 31.9. Getinge AB
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. Samsung Biologics Co. Ltd.
  • 31.12. Eppendorf AG
  • 31.13. Repligen Corporation
  • 31.14. Takara Bio Inc.
  • 31.15. KBI Biopharma Inc.

32. Global Upstream Bioprocessing Market Competitive Benchmarking

33. Global Upstream Bioprocessing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Upstream Bioprocessing Market

35. Upstream Bioprocessing Market Future Outlook and Potential Analysis

  • 35.1 Upstream Bioprocessing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Upstream Bioprocessing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Upstream Bioprocessing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer